Health Canada
www.hc-sc.gc.ca
Common menu bar links
Institutional links
About Health Canada
Access to Information Requests Completed - February 2011
This content was archived on June 24, 2013.
Archived Content
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)
If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.
Acronyms and Descriptions
- AER
- Adverse Reaction Report (Adverse Event)
- AHRC
- Assisted Human Reproduction Canada
- CDSA
- Controlled Drugs and Substances Act
- DIN
- Drug Identification Number
- FASD
- Fetal Alcohol Spectrum Disorder
- FTCS
- Federal Tobacco Control Strategy
- NPN
- Natural Product Number
- RFP
- Request for proposal
- SAP
- Special Authorization Program
Completed Requests
| Request # | Request text summary | Status of Completed Request |
|---|---|---|
| A-2008-00485 | All briefs and submissions tabled within the consultation for the "Proposal to regulate little cigars under the Tobacco (Access) Regulations" launched on May 30, 2008 and ending on July 30, 2008. | Disclosed in part |
| A-2008-01042 | Summary or final reports, not publicly released, on violations of regulations on advertising and promotion of drug products for human use. (Mar 1, 2007 to Feb 28, 2009). | Disclosed in part |
| A-2008-01153 | Information regarding the product Replagal. | Disclosed in part |
| A-2009-00042 | Information regarding the Class 3 licensing of Magellan Dental Arts Ltd. | Disclosed in part |
| A-2009-00597 | Information regarding the product Kyolic Aged Garlic Extract Extra Strength One-A-Day; A.G.E., NPN 80004073. | Disclosed in part |
| A-2009-01027 | All of the non-compliant inspection reports for consumer products relating to toys. (Jan 1, 2008 to Dec 3, 2009). | Disclosed in part |
| A-2009-01047 | Information related to the H1N1 pandemic and Health Minister Leona Aglukkaq. | Disclosed in part |
| A-2009-01077 | All contracts entered into with Dr. John O'Connor for physician services provided directly or indirectly to Alberta First Nations communities of Fort Mackay, Fort Chipewyan (Fort Chip) and Janvier over the past 10 years. | Disclosed in part |
| A-2009-01093 | Access to an electronic copy of the data contained in the Product Safety Information System (PSIS). | Disclosed in part |
| A-2009-01241 | All adverse reaction information and any other material related to potential safety risks with respect to the products Yaz and Yasmin. (2004 to Feb 2, 2010). | Disclosed in part |
| A-2009-01281 | All documents to/from Dr. Hakique Virani, Director, Primary Health Care, pertaining to health studies in the community of Fort Chipewyan, Alberta and/or Dr. John O'Connor. (Dec 1, 2006 to May 1, 2007 & Jan 1, 2009 to Nov 30, 2009). | Disclosed in part |
| A-2010-00013 | All written reports and/or summaries of findings for all on-site inspections of the GlaxoSmithKline Inc facility in Ste-Foy, Qc. by inspectors from the Biologics and Genetic Therapies Directorate. (Oct 1, 2009 to Nov 30, 2009). | Disclosed in part |
| A-2010-00031 | All information regarding the teleconference of the cribs, cradles and bassinets/playpen committee. (Apr 16, 2009 to Apr 1, 2010). | Disclosed in part |
| A-2010-00166 | Letter sent to Kata Kitaljevich, acting director of the Assisted Human Reproduction Implementation Office, in January 2007, by some members of the panel on screening candidates of the board of AHRC. | Disclosed in part |
| A-2010-00227 | All documentation regarding serious and unexpected adverse drug reactions that have occurred during clinical trials at Anapharm from 2002 to present (Jun 1, 2010). | Disclosed in part |
| A-2010-00242 | All correspondence Chandrani Wijayasinghe and the following individuals: Tyler White, Joan Yee, Simon Sihota, and Art Murphy. (Jan 1, 2007 to Jun 2, 2010). | Disclosed in part |
| A-2010-00438 | Information regarding air quality tests on certain of the homes in which RetroFoam was installed. | Disclosed in part |
| A-2010-00505 | AERs. Report numbers: 000309170, 000309258, 000311813, 000311815 and 000311816. | Disclosed in part |
| A-2010-00511 | Information regarding the product Vitamin B12 1200 Mcg Timed Release, NPN 00480878 by Jamieson Laboratories Ltd. | All disclosed |
| A-2010-00512 | Information regarding the product B Complex 100 Timed Release, NPN 00498815 by Jamieson Laboratories Ltd. | All disclosed |
| A-2010-00558 | Any report showing amounts paid in wages to Health Canada employees including bonuses and overtime hours from the year 2000 to the present date, July 28, 2010. | All disclosed |
| A-2010-00635 | All Test results of all flammability test for all makes and models of tents tested by Health Canada. (Jan 1, 2000 to Aug 31, 2010). | Disclosed in part |
| A-2010-00642 | Information regarding the product Ketorolac Tromethamine Injection, USP, DIN 02239944 by Sandoz Canada Incorporated. | Disclosed in part |
| A-2010-00663 | Copies of all product monographs (old and current) for the product Micardis Plus (hydrochlorothiazide telmisartan). | Disclosed in part |
| A-2010-00770 | Copy of any presentation/deck pertaining to the future of the Federal Tobacco Control Strategy (FTCS), which was provided to the Deputy Minister or Minister's office for consideration between Jan 1, 2010 and Oct 12, 2010. | Disclosed in part |
| A-2010-00771 | Documents which list all grants and contributions received, and the status/future of any financial grants and/or contributions, by third parties for the purpose of tobacco control activities. For 2008, 2009 and 2010. | Disclosed in part |
| A-2010-00793 | Information regarding the product CO PANTOPRAZOLE, DIN 02300486 by Cobalt Pharmaceuticals Company. | Disclosed in part |
| A-2010-00805 | Information about the unscheduled drug Mephedrone and similar substances. Inquiries pertained to the legal status of these substances with respect to the Controlled Drugs and Substances Act (CDSA), and the procedure used in making status decisions. | All disclosed |
| A-2010-00823 | AER for the product MAGNEVIST. Report number: 000349791. | Disclosed in part |
| A-2010-00836 | AERs for the product Oxytrol by Watson Pharmaceuticals. Report numbers: 000335868 and 000340086. | Disclosed in part |
| A-2010-00846 | Information regarding the product SANDOZ RISEDRONATE, DIN 02327295 by Sandoz Canada Incorporated. | Disclosed in part |
| A-2010-00856 | Information regarding the product EXTRA STRENGTH NEOCITRAN TOTAL SYMPTOM RELEIF - SUGAR FREE, DIN 02319195 by NOVARTIS CONSUMER HEALTH CANADA INC. | All disclosed |
| A-2010-00869 | Information regarding the product PROTOPIC (Tacrolimus), DINs 02244148 and 02244149 by Astellas Pharma Canada Inc. | Disclosed in part |
| A-2010-00898 | All briefing notes created or sent to the Minister of Health from October 14, 2010 to October 31, 2010. | Disclosed in part |
| A-2010-00914 | Copies of the two Signal Assessments of Bisphosphonates and Ocular Disorders issued in the years 2005 and 2010. | Disclosed in part |
| A-2010-00922 | Information regarding the conclusion of complaint 51991. (Dec 7, 2009 to Apr 22, 2010). | All disclosed |
| A-2010-00953 | All records generated by the two-year project surveying the presence of Radon gas that have been generated since Jan 1, 2010 to present (Dec 7, 2010). | All disclosed |
| A-2010-00954 | All ministerial briefing notes on radon gas. (Jan 1, 2010 to Dec 1, 2010) | All disclosed |
| A-2010-00973 | The final version (or the most recent draft) regarding A Special Study of the Fetal Alcohol Spectrum Disorder (FASD) Mentoring Program in First Nations Communities done by The Whetstone Group (Contract number 1000091411 - 2nd Solicitation). | Disclosed in part |
| A-2010-00975 | All information regarding NeilMed Pharmaceuticals Inc. pertaining sale of Natural Health Products without valid market authorization. | All disclosed |
| A-2010-00976 | All information related to the classification of sodium chloride (SC) and NeilMed Pharmaceuticals | Disclosed in part |
| A-2010-00984 | AERs for the product ALVESCO (ciclesonide) by Watson Pharmaceuticals. Report numbers: 000347718, 000348633 and 000349297. | Disclosed in part |
| A-2010-00986 | AER for the product RESULTZ (isopropyl myristate). Report number: 000349728. | Disclosed in part |
| A-2010-00991 | Records previously disclosed regarding applications made by the Toronto Institute of Pharmaceutical Technology or Transpharm to conduct human clinical trials. Requests numbers: A-2003-00050 and A-2004-00097. | Disclosed in part |
| A-2010-01001 | Information regarding the product Herbal Diuretic, NPN 02078058 by Jamieson Laboratories Ltd. | Disclosed in part |
| A-2010-01007 | Information on the Natural Health Products Directorate's (NHPD) Standards of Evidence Framework. | All disclosed |
| A-2010-01014 | Number of SAPs for Fotolyn (Pralatrexate) for the month of December 2010. | All disclosed |
| A-2010-01021 | AER for the product YAZ. Report number: 000352296. | Disclosed in part |
| A-2010-01022 | AER for the product ADALAT XL. Report number: 00352006. | Disclosed in part |
| A-2010-01023 | AERs for the product AVELOX. Report numbers: 000351432, 000351975 and 000352411. | Disclosed in part |
| A-2010-01024 | AERs for the product CIPRO XL. Report numbers: 000351432, 000351641 and 000352711. | Disclosed in part |
| A-2010-01025 | AER for the product Gadovist. Report number: 000350482. | Disclosed in part |
| A-2010-01026 | AERs for the product Magnevist. Report numbers: 000350595 and 000350660. | Disclosed in part |
| A-2010-01027 | AERs for the product MIRENA. Report numbers: 000350938 and 000351784. | Disclosed in part |
| A-2010-01028 | AERs for the product Nexavar. Report numbers: 000350641 and 000352068. | Disclosed in part |
| A-2010-01029 | AER for the product XARELTO. Report number: 000351849. | Disclosed in part |
| A-2010-01030 | AER for the product Yasmin. Report number: 000350790. | Disclosed in part |
| A-2010-01031 | Information for the contract awarded to RISK SCIENCES INTERNATIONAL with reference number 4500241081 on 1/912010 valued at $123961 for Research contracts. | Disclosed in part |
| A-2010-01032 | All materials related to the decision by Health Canada to deny or delay the regulatory approval of the prescription medication Byetta (exenatide). | All exempted |
| A-2010-01053 | List of all Access to Information requests completed by Health Canada since January 2005 to April 2008 and November 2010. | Disclosed in part |
| A-2010-01054 | List of all employees of your institution, including name, classification and salary range. | All disclosed |
| A-2010-01066 | Copies of the RFP and all amendments, regarding contract #H1021-04-ONTN 01, Nursing Services in Northern Ontario. | All disclosed |
| A-2010-01068 | Information relating the public involvement activities undertaken by Health Products and Food Branch. Information related to all consultations in which, generally speaking, food safety, nutrition and quality were issues for which consultations were based. (Jan 1, 2004 to Dec 21, 2010). | All disclosed |
| A-2010-01079 | AER for the product ADALAT XL. Report number: 000353009. | Disclosed in part |
| A-2010-01080 | AERs for the product AVELOX. Report numbers: 000352743, 000353397, 000353482, 000353500, 000353587, 000353588 and 000353689. | Disclosed in part |
| A-2010-01081 | AERs for the product CIPRO. Report numbers: 000352759 and 000354148. | Disclosed in part |
| A-2010-01083 | AERs for the product YAZ. Report numbers: 000353965 and 000354196. | Disclosed in part |
| A-2010-01084 | AERs for the product XARELTO. Report numbers: 000354077 and 000354079. | Disclosed in part |
| A-2010-01085 | AERs for the product MIRENA. Report numbers: 000352577 and 000353060. | Disclosed in part |
| A-2010-01092 | AERs for the product Singulair. Report numbers: 000340121 and 000340891. | Disclosed in part |
| A-2010-01109 | AER. Report number: 000308297. | All disclosed |
| A-2010-01136 | AER. Report number: 000356461. | Disclosed in part |
| A-2010-01138 | AER. Report number: 000355298. | Disclosed in part |
| A-2010-01139 | AER. Report number: 000359318. | Disclosed in part |
| A-2010-01140 | AER. Report number: 000353019. | Disclosed in part |
| A-2010-01141 | AER. Report number: 000355269. | Disclosed in part |
| A-2010-01142 | AER. Report number: 000359336. | Disclosed in part |
| A-2010-01145 | AER for the product Coversyl 8 mg. Report number: 000346885. | Disclosed in part |
| A-2010-01146 | AER for the product Coversyl. Report number: 000348765. | Disclosed in part |
| A-2010-01147 | AER for the product Coversyl 4 mg. Report number: 000350677. | Disclosed in part |
| A-2010-01148 | AER for the product Coversyl 4 mg. Report number: 000351310. | Disclosed in part |
| A-2010-01149 | AER for the product Coversyl 4 mg. Report number: 000352110. | Disclosed in part |
| A-2010-01150 | AERs for the product Gliclazide MR. Report numbers: 000349815 and 000352783. | Disclosed in part |
| A-2010-01164 | ALL CALLUPS processed by this institution in the NATIONAL CAPITAL REGION under the terms of the SUPPLY ARRANGEMENT for temporary Help Services during the period of December 2010. | Disclosed in part |
| A-2010-01169 | All appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during December 2010. | All disclosed |
| A-2010-01174 | AERs for the product Cipralex. Report numbers: 000341142, 000343335, 000344766, 000345817 and 000346438. | Disclosed in part |
| A-2010-01176 | AER for the product Ebexa. Report number: 000341301. | Disclosed in part |
| A-2010-01203 | Information regarding the product BYETTA (exenatide), DINs 02361809 and 02361817 by ELI LILLY CANADA INC. | All exempted |
| A-2010-01204 | AER. Report number: 000346812. | Disclosed in part |
| A-2010-01205 | AER. Report number: 000349183. | Disclosed in part |
| A-2010-01206 | AER. Report number: 000349827. | Disclosed in part |
| A-2010-01207 | AER. Report number: 000352409. | Disclosed in part |
| A-2010-01208 | AER. Report number: 000351968. | Disclosed in part |
| A-2010-01209 | AER for the product Pentasa. Report number: 000348456. | Disclosed in part |
| A-2010-01224 | AER for the product Taxotere (docetaxel). Report number: 000360386. | Disclosed in part |
| A-2010-01247 | Information regarding the product Greens+ Extra Energy, NPN 80010572 by Genuine Health. | Disclosed in part |
